Cingulate (CINGW) Non-Current Assets (2021 - 2026)
Cingulate's (CINGW) quarterly Non-Current Assets came in at $2.9 million in Q2 2026, down 6.74% quarter-over-quarter from $3.1 million in Q4 2025.
Analysis
Cingulate (CINGW) Non-Current Assets (2021 - 2026) Analysis & Trends
Cingulate (CINGW) has reported Non-Current Assets for 6 consecutive years, with $2.9 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Non-Current Assets changed N/A year-over-year to $2.9 million; the trailing twelve-month figure through Jun 2026 stood at $11.0 million (changed N/A YoY), and the FY2025 full-year result was $3.1 million, up 39.09% from the prior year.
- Non-Current Assets fell to $2.9 million in Q2 2026 per CINGW's latest filing, from $3.1 million in the prior quarter.
- Across five years, Non-Current Assets topped out at $3.9 million in Q1 2022 and bottomed at $2.0 million in Q1 2025.
- Historically, Non-Current Assets has averaged $3.0 million across 5 years, with a median of $3.0 million in 2023.
- The widest YoY moves for Non-Current Assets: up 39.09% in 2025, down 29.02% in 2025.
- Over 5 years, Non-Current Assets stood at $3.5 million in 2022, then slipped by 17.61% to $2.9 million in 2023, then fell by 24.35% to $2.2 million in 2024, then jumped by 39.09% to $3.1 million in 2025, then decreased by 6.74% to $2.9 million in 2026.
- According to Business Quant data, Non-Current Assets over the past three periods registered $2.9 million, $3.1 million, and $3.1 million for Q2 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 644.46 Bn | 623.70 Bn | 17.26 Bn | 141.29 Bn |
| 2 | AbbVie | 440.11 Bn | 433.54 Bn | 12.70 Bn | 101.45 Bn |
| 3 | Merck | 365.04 Bn | 357.90 Bn | 12.21 Bn | 125.00 Mn |
| 4 | Novartis Ag | 266.82 Bn | 259.13 Bn | 11.24 Bn | 94.68 Bn |
| 5 | Pfizer | 159.14 Bn | 147.45 Bn | 10.94 Bn | 159.77 Bn |
| 6 | Sanofi | 52.47 Bn | 45.09 Bn | 10.79 Bn | 113.37 Bn |
| 7 | Revolution Medicines | 44.26 Bn | 44.26 Bn | - | 294.93 Mn |
| 8 | Incyte | 25.32 Bn | 20.79 Bn | 1.57 Bn | 1.85 Bn |
| 9 | United Therapeutics | 21.46 Bn | 18.80 Bn | 683.80 Mn | 3.74 Bn |
| 10 | Cingulate | 100,214.03 | 100,214.03 | - | 2.86 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.86 Mn |
| Dec 31, 2025 | 3.07 Mn |
| Sep 30, 2025 | 3.09 Mn |
| Mar 31, 2025 | 1.96 Mn |
| Dec 31, 2024 | 2.20 Mn |
| Sep 30, 2024 | 2.24 Mn |
| Jun 30, 2024 | 2.61 Mn |
| Mar 31, 2024 | 2.77 Mn |
| Dec 31, 2023 | 2.91 Mn |
| Sep 30, 2023 | 2.97 Mn |
| Jun 30, 2023 | 3.19 Mn |
| Mar 31, 2023 | 3.41 Mn |
| Dec 31, 2022 | 3.54 Mn |
| Sep 30, 2022 | 3.54 Mn |
| Jun 30, 2022 | 3.70 Mn |
| Mar 31, 2022 | 3.86 Mn |
| Dec 31, 2021 | 4.00 Mn |